Bioage Labs Stock Performance
| BIOA Stock | 20.16 1.35 6.28% |
BioAge Labs holds a performance score of 25 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.11, which signifies a somewhat significant risk relative to the market. BioAge Labs returns are very sensitive to returns on the market. As the market goes up or down, BioAge Labs is expected to follow. Use BioAge Labs total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on BioAge Labs.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BioAge Labs are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BioAge Labs sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (6.28) | Five Day Return 34.4 | Year To Date Return 57.13 | Ten Year Return 10.1 | All Time Return 10.1 |
1 | How strong is BioAge Labs Inc. stock earnings growth - July 2025 Technicals Technical Pattern Alert System - newser.com | 10/28/2025 |
2 | Is BioAge Labs Inc. stock a buy on weakness - 2025 Short Interest Risk Adjusted Buy and Sell Alerts - newser.com | 11/20/2025 |
3 | Disposition of 20000 shares by Ashworth Andrew P. of BioAge Labs, at 7.05 subject to Rule 16b-3 | 11/28/2025 |
4 | BioAge Labs stock rating upgraded by Morgan Stanley on promising BGE-102 data - Investing.com | 12/05/2025 |
5 | Morgan Stanley Upgrades BioAge Labs - Nasdaq | 12/08/2025 |
6 | Disposition of 18000 shares by Rubin Paul D of BioAge Labs, at 12.0 subject to Rule 16b-3 | 12/09/2025 |
7 | BioAge Labs Stock Gains Momentum on Promising Trial Data - AD HOC NEWS | 12/17/2025 |
8 | BioAge Labs, Inc. Class Action The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 ... | 12/31/2025 |
9 | Disposition of 7433 shares by Rubin Paul D of BioAge Labs at 12.8468 subject to Rule 16b-3 | 01/02/2026 |
10 | BioAge Labs Shares Gap Up Time to Buy | 01/07/2026 |
11 | Institutional investors are BioAge Labs, Inc.s biggest bettors and were rewarded after last weeks US51m market cap gain | 01/12/2026 |
12 | BioAge Labs Shares Down 6.1 percent on Insider Selling | 01/16/2026 |
| Begin Period Cash Flow | 25 M | |
| Total Cashflows From Investing Activities | -366 K | |
| Free Cash Flow | -51.9 M |
BioAge Labs Relative Risk vs. Return Landscape
If you would invest 530.00 in BioAge Labs on October 21, 2025 and sell it today you would earn a total of 1,486 from holding BioAge Labs or generate 280.38% return on investment over 90 days. BioAge Labs is currently generating 2.425% in daily expected returns and assumes 7.4701% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than BioAge, and 52% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioAge Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAge Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioAge Labs, and traders can use it to determine the average amount a BioAge Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3246
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | BIOA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average BioAge Labs is performing at about 25% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioAge Labs by adding it to a well-diversified portfolio.
BioAge Labs Fundamentals Growth
BioAge Stock prices reflect investors' perceptions of the future prospects and financial health of BioAge Labs, and BioAge Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioAge Stock performance.
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (11.27) % | ||||
| Current Valuation | 444.19 M | ||||
| Shares Outstanding | 35.86 M | ||||
| Price To Earning | (0.84) X | ||||
| Price To Book | 2.61 X | ||||
| Price To Sales | 122.16 X | ||||
| Gross Profit | (3.74 M) | ||||
| EBITDA | (68.58 M) | ||||
| Net Income | (71.11 M) | ||||
| Cash And Equivalents | 4.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 8.7 M | ||||
| Debt To Equity | 172.10 % | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 7.74 X | ||||
| Cash Flow From Operations | (51.52 M) | ||||
| Earnings Per Share | 13.61 X | ||||
| Market Capitalization | 722.84 M | ||||
| Total Asset | 358.23 M | ||||
| Retained Earnings | (252.81 M) | ||||
| Working Capital | 329.33 M | ||||
| Current Asset | 10.84 M | ||||
| Current Liabilities | 29.68 M | ||||
About BioAge Labs Performance
By analyzing BioAge Labs' fundamental ratios, stakeholders can gain valuable insights into BioAge Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioAge Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioAge Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.18) | (0.19) | |
| Return On Capital Employed | (0.21) | (0.22) | |
| Return On Assets | (0.18) | (0.19) | |
| Return On Equity | (0.25) | (0.24) |
Things to note about BioAge Labs performance evaluation
Checking the ongoing alerts about BioAge Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioAge Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioAge Labs is way too risky over 90 days horizon | |
| BioAge Labs appears to be risky and price may revert if volatility continues | |
| BioAge Labs has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (71.11 M) with loss before overhead, payroll, taxes, and interest of (3.74 M). | |
| BioAge Labs currently holds about 4.63 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| BioAge Labs has a frail financial position based on the latest SEC disclosures | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: BioAge Labs Shares Down 6.1 percent on Insider Selling |
- Analyzing BioAge Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioAge Labs' stock is overvalued or undervalued compared to its peers.
- Examining BioAge Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioAge Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioAge Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioAge Labs' stock. These opinions can provide insight into BioAge Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioAge Stock analysis
When running BioAge Labs' price analysis, check to measure BioAge Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs is operating at the current time. Most of BioAge Labs' value examination focuses on studying past and present price action to predict the probability of BioAge Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs' price. Additionally, you may evaluate how the addition of BioAge Labs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |